186 related articles for article (PubMed ID: 22772608)
1. Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas.
Gousias K; Becker AJ; Simon M; Niehusmann P
J Neurooncol; 2012 Sep; 109(3):545-53. PubMed ID: 22772608
[TBL] [Abstract][Full Text] [Related]
2. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
Gousias K; Niehusmann P; Gielen G; Simon M; Boström J
J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
[TBL] [Abstract][Full Text] [Related]
3. Karyopherin a2 and chromosome region maintenance protein 1 expression in meningiomas: novel biomarkers for recurrence and malignant progression.
Gousias K; Niehusmann P; Gielen GH; Simon M
J Neurooncol; 2014 Jun; 118(2):289-296. PubMed ID: 24664371
[TBL] [Abstract][Full Text] [Related]
4. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
Haapasalo J; Nordfors K; Granberg KJ; Kivioja T; Nykter M; Haapasalo H; Soini Y
Histol Histopathol; 2018 Aug; 33(8):791-801. PubMed ID: 29441509
[TBL] [Abstract][Full Text] [Related]
5. Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.
Mäkelä KS; Haapasalo JA; Ilvesaro JM; Parkkila S; Paavonen T; Haapasalo HK
Histol Histopathol; 2014 Sep; 29(9):1161-8. PubMed ID: 24599602
[TBL] [Abstract][Full Text] [Related]
6. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
7. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas.
Antonelli M; Buttarelli FR; Arcella A; Nobusawa S; Donofrio V; Oghaki H; Giangaspero F
J Neurooncol; 2010 Sep; 99(2):209-15. PubMed ID: 20174854
[TBL] [Abstract][Full Text] [Related]
9. WT1 Clone 6F-H2 Cytoplasmic Expression Differentiates Astrocytic Tumors from Astrogliosis and Associates with Tumor Grade, Histopathology, IDH1 Status, Apoptotic and Proliferative Indices: A Tissue Microarray Study.
Abd El-Hafez A; Ismail Hany HSED
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2403-2413. PubMed ID: 32856872
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas.
Varughese RK; Skjulsvik AJ; Torp SH
Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203
[TBL] [Abstract][Full Text] [Related]
11. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
Reuss DE; Sahm F; Schrimpf D; Wiestler B; Capper D; Koelsche C; Schweizer L; Korshunov A; Jones DT; Hovestadt V; Mittelbronn M; Schittenhelm J; Herold-Mende C; Unterberg A; Platten M; Weller M; Wick W; Pfister SM; von Deimling A
Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834
[TBL] [Abstract][Full Text] [Related]
12. CXCR7 and CXCR4 Expressions in Infiltrative Astrocytomas and Their Interactions with HIF1α Expression and IDH1 Mutation.
Bianco AM; Uno M; Oba-Shinjo SM; Clara CA; de Almeida Galatro TF; Rosemberg S; Teixeira MJ; Nagahashi Marie SK
Pathol Oncol Res; 2015 Apr; 21(2):229-40. PubMed ID: 24970694
[TBL] [Abstract][Full Text] [Related]
13. High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas.
Hatanpaa KJ; Hu T; Vemireddy V; Foong C; Raisanen JM; Oliver D; Hiemenz MC; Burns DK; White CL; Whitworth LA; Mickey B; Stegner M; Habib AA; Fink K; Maher EA; Bachoo RM
J Neurooncol; 2014 Mar; 117(1):183-189. PubMed ID: 24519516
[TBL] [Abstract][Full Text] [Related]
14. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.
Shirahata M; Ono T; Stichel D; Schrimpf D; Reuss DE; Sahm F; Koelsche C; Wefers A; Reinhardt A; Huang K; Sievers P; Shimizu H; Nanjo H; Kobayashi Y; Miyake Y; Suzuki T; Adachi JI; Mishima K; Sasaki A; Nishikawa R; Bewerunge-Hudler M; Ryzhova M; Absalyamova O; Golanov A; Sinn P; Platten M; Jungk C; Winkler F; Wick A; Hänggi D; Unterberg A; Pfister SM; Jones DTW; van den Bent M; Hegi M; French P; Baumert BG; Stupp R; Gorlia T; Weller M; Capper D; Korshunov A; Herold-Mende C; Wick W; Louis DN; von Deimling A
Acta Neuropathol; 2018 Jul; 136(1):153-166. PubMed ID: 29687258
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and radiographic correlates of a prospectively collected molecularly profiled cohort of IDH1/2-wildtype astrocytomas.
Lin AL; Rosenblum M; Mellinghoff IK; Tabar VS; Ogilvie S; Schaff L; Yang TJ; Young RJ; Taylor BS; Jonsson P; Bale TA
Brain Pathol; 2020 May; 30(3):653-660. PubMed ID: 31984581
[TBL] [Abstract][Full Text] [Related]
16. TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas.
Rorive S; Lopez XM; Maris C; Trepant AL; Sauvage S; Sadeghi N; Roland I; Decaestecker C; Salmon I
Mod Pathol; 2010 Oct; 23(10):1418-28. PubMed ID: 20693981
[TBL] [Abstract][Full Text] [Related]
17. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.
Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D
Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated Hsp27 is mutually exclusive with ATRX loss and the IDH1
Cai HQ; Wang PF; Zhang HP; Cheng ZJ; Li SW; He J; Zhang Y; Hao JJ; Wang MR; Yan CX; Wan JH
J Clin Pathol; 2018 Aug; 71(8):702-707. PubMed ID: 29550762
[TBL] [Abstract][Full Text] [Related]
20. Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas.
Mäkelä K; Nordfors K; Finne J; Jokilammi A; Paavonen T; Haapasalo H; Korja M; Haapasalo J
BMC Cancer; 2014 Aug; 14():623. PubMed ID: 25164322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
